News

Yahoo Finance2y
Urica Therapeutics Expands Exclusive License Agreement with Fuji Yakuhin Co. Ltd. to Develop Dotinurad in Additional Territories Including Turkey and the Middle East and North ...
About Dotinurad In May 2021, Fortress announced an exclusive license agreement between its subsidiary, Urica Therapeutics, Inc. (formerly UR-1 Therapeutics, Inc.), and Fuji Yakuhin Co. Ltd. to ...
Yahoo Finance2y
Urica Therapeutics Appoints Seasoned Biotech Executive Jay D. Kranzler, M.D., Ph.D., as Chairman and Chief Executive Officer - Yahoo Finance
Company also strengthens Board of Directors with addition of Stanford Professor Vibeke Strand, M.D., MACR, FACPMIAMI, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Urica Therapeutics, Inc. (“Urica” or the ...
Stockhouse1y
Urica Therapeutics Announces Topline Data from the Phase 1 Clinical Trial Evaluating Dotinurad in Healthy Volunteers in the United States | NDAQ:FBIO | Press Release - Stockhouse
(2023-06-29 | NDAQ:FBIO) Urica Therapeutics Announces Topline Data from the Phase 1 Clinical Trial Evaluating Dotinurad in Healthy Volunteers in the United States (2023-06-29 ... Tablets in Japan) was ...
FierceBiotech2y
Chutes & Ladders—Fortress-owned Urica unites around new CEO Kranzler
Fortress biotech subsidiary Urica Therapeutics has found a new leader, naming Jay Kranzler, M.D., Ph.D., chairman and CEO as the company looks to replicate clinical success of its gout treatment ...